Menu
Your Cart

I-Guard Eye Drop 0.5% — Chloramphenicol Antibiotic by Beximco

I-Guard Eye Drop 0.5% — Chloramphenicol Antibiotic by Beximco
I-Guard Eye Drop 0.5% — Chloramphenicol Antibiotic by Beximco
Tk34.40
0 Pcs sold
5368 Interested

Available Options

I-Guard Eye Drop 0.5% — Chloramphenicol | Beximco Pharmaceuticals

Generic NameChloramphenicol 0.5% w/v Eye Drops
Strength0.5% (5mg/ml)
Drug ClassBroad-Spectrum Antibiotic (Ophthalmic)
ManufacturerBeximco Pharmaceuticals Ltd.
RouteTopical — Ophthalmic (Eye)
Prescription StatusPrescription Recommended

Overview

I-Guard Eye Drop 0.5% is a standard-strength Chloramphenicol ophthalmic solution for bacterial conjunctivitis and superficial eye infections. Chloramphenicol 0.5% is one of the most widely used first-line topical antibiotics for eye infections globally due to its broad spectrum of coverage and well-established safety profile for short-term use. For diabetic patients, maintaining ocular health is critical — prompt treatment of infections prevents complications on already compromised diabetic eyes.

Mechanism of Action

Chloramphenicol inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit and blocking the peptidyl transferase reaction. Bacteriostatic activity against most organisms. Covers: Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae, Moraxella lacunata, Neisseria gonorrhoeae, and many other bacterial conjunctivitis pathogens.

Indications

  • Acute and chronic bacterial conjunctivitis
  • Blepharoconjunctivitis
  • Trachoma (adjunct to systemic therapy)
  • Bacterial keratitis — superficial
  • Post-operative prophylaxis

Dosage

IndicationDoseFrequencyDuration
Bacterial conjunctivitis1–2 drops per affected eyeEvery 2–6 hours5–7 days
Severe/persistent2 dropsEvery 2 hours initiallyUp to 14 days max

Critical Diabetic Patient Warnings

  • Impaired corneal healing: Diabetic corneas heal more slowly — if bacterial infection progresses to keratitis, early ophthalmologist review is essential
  • Do not self-treat repeatedly: Recurrent eye infections in diabetics may signal worsening immune function or glucose control — review HbA1c
  • Distinguish infectious vs. diabetic eye disease: Redness and discharge may be due to infectious conjunctivitis OR diabetic vascular complications — confirm diagnosis
  • Avoid prolonged courses: Use for minimum effective duration; prolonged use without review is not safe

Side Effects

SystemSide EffectSeverity
LocalTransient stinging or burning on instillationMild
LocalAllergic conjunctivitis / contact dermatitis of eyelidsModerate
Systemic (rare)Aplastic anaemia (idiosyncratic, very rare with topical use)Rare — serious

Contraindications

  • Known hypersensitivity to chloramphenicol
  • Herpes simplex keratitis (viral — antibiotic ineffective)
  • Fungal ocular infections
  • Neonates — risk of systemic absorption and grey baby syndrome
  • History of blood dyscrasia or aplastic anaemia

Storage

Store at 15–25°C. Do not freeze. Keep tightly closed. Protect from light. Discard 28 days after opening.

Frequently Asked Questions

Q: What is the difference between I-Guard Eye Drop 0.5% and I-Guard Eye Drop 10ml?
A: Both contain Chloramphenicol 0.5%. The 10ml bottle is a larger economy size for longer courses; the standard bottle is for typical 5–7 day courses. Active ingredient and dosing are identical.

Q: Is this the same as I-Guard Ciprofloxacin drops?
A: No. I-Guard is available in two antibiotic formulations: Chloramphenicol (this product) and Ciprofloxacin 0.3%. They cover overlapping but different bacterial spectrums. Your physician will select the appropriate one based on your infection.


Medical Disclaimer: I-Guard Eye Drop 0.5% (Chloramphenicol) is for short-term treatment of bacterial eye infections. Diabetic patients with eye symptoms must seek prompt medical assessment. Avoid prolonged use. Not for viral or fungal eye infections. This information is for educational purposes only and does not constitute medical advice. Always follow your physician's instructions.

Write a review

Note: HTML is not translated!
Bad Good